Atherotech Diagnostics Lab Release: VAP&#0174 Lipid Panel Demonstrates Value Of Cholesterol Subfraction Measurement In Heart Disease Treatment And Risk Assessment

Published: Nov 19, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

DALLAS--(BUSINESS WIRE)--Researchers using the Atherotech VAP® Lipid Panel demonstrated the comprehensive lipid profile’s value in heart disease treatment and risk assessment. Through measurement of HDL cholesterol subfractions and remnant lipoproteins, the VAP Lipid Panel was able to identify specific lipid disorders for personalized treatment that may lead to improved outcomes in two scientific abstracts presented today at the American Heart Association (AHA) Scientific Sessions 2013 in Dallas.

Help employers find you! Check out all the jobs and post your resume.

Back to news